{"id":51,"date":"2025-10-13T19:54:18","date_gmt":"2025-10-13T17:54:18","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&p=51"},"modified":"2026-06-14T22:22:13","modified_gmt":"2026-06-14T20:22:13","slug":"tirzepatidi-mounjaro","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/fi\/shop\/tirzepatide-mounjaro\/","title":{"rendered":"Tirzepatidi \/ Mounjaro"},"content":{"rendered":"

Tirzepatidi - kaksoisagonistinen peptidi aineenvaihdunnan ja painonhallinnan hoitoon<\/strong><\/p>\n

Koostumus:<\/strong>\u00a0Tirzepatidi (lyofilisoitu peptidijauhe)
Kategoria:<\/strong> Peptidi
Lomake:<\/strong> Injektiopullo, jossa on kylm\u00e4kuivattua jauhetta
Hallinto:<\/strong> Ihonalainen injektio sen j\u00e4lkeen, kun se on saatettu bakteriostaattiseen veteen<\/p>\n

\n

Mik\u00e4 on tirzepatidi?<\/h3>\n

Tirzepatidi<\/strong> on kaksoisinkretiinireseptoriagonisti<\/strong> joka aktivoi samanaikaisesti GLP-1 (glukagonin kaltainen peptidi-1)<\/strong>ja GIP (glukoosiriippuvainen insulinotrooppinen polypeptidi)<\/strong> reseptorit.
T\u00e4m\u00e4 kaksoismekanismi tekee siit\u00e4 seuraavan sukupolven peptidi<\/strong> osoitteessa aineenvaihdunnan ja painon s\u00e4\u00e4telyn tutkimus<\/strong>, yhdist\u00e4m\u00e4ll\u00e4 GLP-1-agonistien glukoosia v\u00e4hent\u00e4v\u00e4t vaikutukset<\/strong> kanssa GIP-stimulaation metaboliset edut.<\/strong><\/p>\n

Aktivoimalla molempia signalointireittej\u00e4 tirzepatidi on osoittanut vahvaa potentiaalia seuraavissa tapauksissa prekliiniset ja kliiniset tutkimukset<\/strong> parantamaan insuliiniherkkyys, kehon rasvan v\u00e4hent\u00e4minen,<\/strong> ja optimoimalla energia-aineenvaihdunta.<\/strong><\/p>\n

\u27a1\ufe0f Ihanteellinen aineenvaihdunnan terveys, insuliinin s\u00e4\u00e4tely,<\/strong> ja lihavuuden mekanismitutkimus.<\/strong><\/p>\n

\n

T\u00e4rkeimm\u00e4t tutkimustulokset<\/h3>\n

Kahden reseptorin aktivointi:<\/strong> Stimuloi sek\u00e4 GLP-1<\/strong> ja GIP-reseptorit<\/strong> synergistist\u00e4 aineenvaihdunnan tehostamista varten.<\/p>\n

Glukoosin s\u00e4\u00e4tely:<\/strong> Edist\u00e4\u00e4 insuliinin eritys<\/strong> ja parantaa glukoosin homeostaasi.<\/strong><\/p>\n

Rasvan v\u00e4hent\u00e4minen:<\/strong> Johtaa kehon rasvan v\u00e4hent\u00e4minen<\/strong> s\u00e4ilytt\u00e4en samalla v\u00e4h\u00e4rasvainen painoindeksi.<\/strong><\/p>\n

Ruokahalun hallinta:<\/strong> S\u00e4\u00e4telee keskeisi\u00e4 mekanismeja, jotka ohjaavat n\u00e4lk\u00e4 ja kyll\u00e4isyys.<\/strong><\/p>\n

Energia-aineenvaihdunta:<\/strong> Parantaa mitokondrioiden tehokkuus<\/strong> ja rasvan hapettuminen.<\/strong><\/p>\n

\n

Annostus ja k\u00e4ytt\u00f6<\/h3>\n

T\u00e4ytet\u00e4\u00e4n uudelleen bakteriostaattinen vesi<\/strong> ennen k\u00e4ytt\u00f6\u00e4.<\/p>\n

Tyypillinen tutkimusalue: 0,25-1,0 mg annosta kohti<\/strong>, ihon alle, kerran tai kahdesti viikossa<\/strong> tutkimusasetelmasta riippuen.<\/p>\n

S\u00e4ilyt\u00e4 rekonstruoitu liuos J\u00e4\u00e4hdytetty<\/strong> ja k\u00e4ytt\u00e4\u00e4 30 p\u00e4iv\u00e4\u00e4.<\/strong><\/p>\n

\n

S\u00e4ilytysohjeet<\/h3>\n
    \n
  • \n

    S\u00e4ilyt\u00e4 osoitteessa 2-8 \u00b0C (36-46 \u00b0F)<\/strong><\/p>\n<\/li>\n

  • \n

    Suojaa valo ja kosteus<\/strong><\/p>\n<\/li>\n

  • \n

    Ei saa j\u00e4\u00e4dytt\u00e4\u00e4<\/strong><\/p>\n<\/li>\n

  • \n

    V\u00e4lt\u00e4 l\u00e4mp\u00f6tilan vaihteluita<\/p>\n<\/li>\n<\/ul>\n

    \n

    Miksi valita tirzepatidi?<\/h3>\n

    Tirzepatidi<\/strong> on yksi kehittyneimm\u00e4t inkretiinipohjaiset peptidit<\/strong> t\u00e4ll\u00e4 hetkell\u00e4 tutkimuksen kohteena.
    Sen kautta kaksoisreseptorin aktivointi<\/strong>, se tarjoaa ainutlaatuinen profiili<\/strong> optimoitu aineenvaihdunnan hallinta ja painonhallinta.<\/strong>
    Sen vaikutukset glukoosiaineenvaihdunta, rasvan hapettuminen,<\/strong> ja energiatase<\/strong> tehd\u00e4 siit\u00e4 arvokas ty\u00f6kalu<\/strong> osoitteessa endokriininen ja metabolinen tutkimus.<\/strong><\/p>\n

    Tilaa tirzepatidi<\/strong>\u00a0ja tutkia sen mahdollisuuksia edistyksellinen aineenvaihdunnan ja lihavuuden tutkimus.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

    Tirzepatide \u00a0\u2013 Dual-Agonist Peptide for Metabolic & Weight Management Composition:\u00a0Tirzepatide (lyophilized peptide powder)Category: PeptideForm: Vial with freeze-dried powderAdministration: Subcutaneous injection after reconstitution with bacteriostatic water What is Tirzepatide? Tirzepatide is a dual incretin receptor agonist that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1)and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.This dual mechanism makes it a next-generation peptide in metabolic and weight regulation research, combining the glucose-lowering effects of GLP-1 agonists with the metabolic advantages of GIP stimulation. By activating both signaling pathways, Tirzepatide has shown strong potential in preclinical and clinical studies for improving insulin sensitivity, reducing body fat, and optimizing energy metabolism. \u27a1\ufe0f Ideal for metabolic health, insulin regulation, and obesity mechanism research. Key Research Findings Dual Receptor Activation: Stimulates both GLP-1 and GIP receptors for synergistic metabolic enhancement. Glucose Regulation: Promotes insulin secretion and improves glucose homeostasis. Fat Reduction: Leads to body fat reduction while maintaining lean body mass. Appetite Control: Regulates central mechanisms controlling hunger and satiety. Energy Metabolism: Enhances mitochondrial efficiency and fat oxidation. Dosage & Application Reconstitute with bacteriostatic water before use. Typical research range: 0.25\u20131.0 mg per application, subcutaneously, once or twice weekly depending on study design. Store the reconstituted solution refrigerated and use within 30 days. Storage Instructions Store at 2\u20138 \u00b0C (36\u201346 \u00b0F) Protect from light and moisture Do not freeze Avoid temperature fluctuations Why Choose Tirzepatide? Tirzepatide is one of the most advanced incretin-based peptides currently under research.Through its dual receptor activation, it offers a unique profile for optimized metabolic control and weight management.Its effects on glucose metabolism, fat oxidation, and energy balance make it a valuable tool in endocrine and metabolic research. Order Tirzepatide\u00a0and explore its potential in advanced metabolic and obesity research.<\/p>","protected":false},"featured_media":126830,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,24,25,27],"product_tag":[],"class_list":["post-51","product","type-product","status-publish","has-post-thumbnail","product_cat-all-products","product_cat-glp-1andmultiagonist","product_cat-metabolismandweightmanagement","product_cat-peptidesandresearchdrugs","entry","has-media","first","instock","purchasable","product-type-variable"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t